KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gilead Sciences (GILD) Receivables (2016 - 2026)

Gilead Sciences filings provide 17 years of Receivables readings, the most recent being $5.5 billion for Q4 2025.

  • On a quarterly basis, Receivables rose 17.99% to $5.5 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $5.5 billion, a 17.99% increase, with the full-year FY2025 number at $5.5 billion, up 17.99% from a year prior.
  • Receivables hit $5.5 billion in Q4 2025 for Gilead Sciences, down from $5.8 billion in the prior quarter.
  • In the past five years, Receivables ranged from a high of $5.8 billion in Q3 2025 to a low of $4.1 billion in Q1 2021.
  • Median Receivables over the past 5 years was $4.8 billion (2021), compared with a mean of $4.9 billion.
  • Biggest five-year swings in Receivables: soared 30.88% in 2024 and later decreased 17.13% in 2025.
  • Gilead Sciences' Receivables stood at $4.7 billion in 2021, then increased by 6.02% to $4.9 billion in 2022, then increased by 13.42% to $5.6 billion in 2023, then decreased by 16.3% to $4.7 billion in 2024, then rose by 17.99% to $5.5 billion in 2025.
  • The last three reported values for Receivables were $5.5 billion (Q4 2025), $5.8 billion (Q3 2025), and $5.1 billion (Q2 2025) per Business Quant data.